Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the Screening for Psychosocial Distress Program, which was launched in 2014 by APOS in partnership with Yale School of Nursing.
Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the Screening for Psychosocial Distress Program, which was launched in 2014 by APOS in partnership with Yale School of Nursing.
Two cancer care professionals, ideally from different disciplines, are trained over two years to implement comprehensive distress screening, evaluate that screening, refer the patient to additional resources if needed and properly document the results.
The participants attend two APOS conferences and learn how to implement live in workshops. Interested cancer care professionals can apply online at http://www.apos-society.org.
Pembrolizumab Plus Chemo Improves Overall Survival in Resectable Gastric Cancer
Ibrutinib-Venetoclax Combo Elicits Durable Complete Responses in TP53+ MCL
Brentuximab Vedotin Triplet Provides Stronger Survival Signal vs R2 in R/R DLBCL
Durvalumab Plus Chemo Shows Sustained Survival Benefit in Advanced Biliary Tract Cancer
2 Commerce Drive
Cranbury, NJ 08512